Neovasc Inc. T.NVC

Primary Symbol: NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > New investors

<< Previous

Bullboard Posts

Next >>

Post by Newport25on Apr 05, 2018 10:57am

106 Views

Post# 27835711

New investors

200k shares @0.045 GLTA

0.5 $ till the end of the quarter
0.15 till the end of april

Theres a really small chance that it gets delisted from the NASDAQ
If that happens I know some promoters that would make a fortune in promoting that stock on the OTC.

NEOVASC reducer is reimbursed in Europe for patients, and looking at the conference call 5 days ago, we will see a lot of positive results in the next 2 months.

0.5 END OF THE QUARTER/0.15 END OF APRIL
DYODD
Newport

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario